Ubs Group Ag Nexalin Technology, Inc. Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NXL
# of Institutions
14Shares Held
276KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY59.8KShares$175,2280.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE55.5KShares$162,5030.81% of portfolio
-
Geode Capital Management, LLC Boston, MA44.1KShares$129,1010.0% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY38.4KShares$112,5500.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.8KShares$93,1150.0% of portfolio
About Nexalin Technology, Inc.
- Ticker NXL
- Exchange
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 7,279,960
- Market Cap $21.3M